J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 109,980 shares at $98.45 ($11.1M) on 2021-01-22, disclosed to the SEC on 2021-01-22.
Open-market sale of $11.1M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.16 | 2,540 | $254K | 2.3% |
| 2 | $100.16 | 2,540 | $254K | 2.3% |
| 3 | $101.09 | 5,993 | $606K | 5.5% |
| 4 | $101.09 | 5,993 | $606K | 5.5% |
| 5 | $101.91 | 3,300 | $336K | 3.0% |
| 6 | $103.23 | 3,895 |
| $402K |
| 3.6% |
| 7 | $103.23 | 3,895 | $402K | 3.6% |
| 8 | $104.13 | 9,156 | $953K | 8.6% |
| 9 | $104.13 | 9,156 | $953K | 8.6% |
| 10 | $105.25 | 4,271 | $450K | 4.1% |
| 11 | $105.25 | 4,271 | $450K | 4.1% |
| 12 | $106.03 | 645 | $68K | 0.6% |
| 13 | $106.03 | 645 | $68K | 0.6% |
| 14 | $106.96 | 200 | $21K | 0.2% |
| 15 | $97.23 | 12,767 | $1.2M | 11.2% |
| 16 | $97.23 | 12,767 | $1.2M | 11.2% |
| 17 | $98.45 | 7,638 | $752K | 6.8% |
| 18 | $98.45 | 7,638 | $752K | 6.8% |
| 19 | $99.35 | 6,520 | $648K | 5.8% |
| 20 | $100.01 | 3,075 | $308K | 2.8% |
| 21 | $100.01 | 3,075 | $308K | 2.8% |
| Total | $100.69 avg | 109,980 | $11.1M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |